Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
SiTime $518 million follow-on offering
The shares are listed on the Nasdaq Global Market
Affimed $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
IVERIC bio $173.4 million stock offering
We advised the underwriters on the SEC-registered equity offering
TaskUs upsized $766.9 million follow-on offering
We advised the underwriters on the secondary offering
Sun Country Airlines Holdings $276.25 million secondary offering
We advised the underwriters on the stock offering
Hulic ¥97 billion common stock offering
We advised international joint lead managers on the global offering of common stock
Manchester United secondary offering
We advised the underwriter on the SEC-registered stock offering